---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-088390"
form_type: "8-K"
ticker: "INVA"
cik: "0001080014"
company_name: "Innoviva, Inc."
filed_at: "2023-08-07T23:59:59+00:00"
generated_at: "2026-06-12T03:43:41.662915+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Innoviva receives Nasdaq notice for audit committee non-compliance after director resignation

## Summary
- Nasdaq notified Innoviva on Aug 2, 2023, that Audit Committee has only 2 independent directors after Dr. Deborah L. Birx resigned July 10.
- Company has cure period until the earlier of next annual meeting or July 10, 2024 to regain compliance with Nasdaq Rule 5605.
- No immediate impact on Nasdaq listing or common stock trading.
- Board is evaluating committee composition and intends to comply fully before cure period ends.

## SEC filing metadata
- accession: 0001104659-23-088390
- form_type: 8-K
- ticker: INVA
- cik: 0001080014
- company_name: Innoviva, Inc.
- filed_at: 2023-08-07T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1080014/000110465923088390/0001104659-23-088390-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1080014/000110465923088390/tm2323042d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-088390
- JSON: https://secwatch.observer/filing/0001104659-23-088390.json
- Plain text: https://secwatch.observer/filing/0001104659-23-088390.txt

## Key facts
- Listing & Compliance Notices
  Innoviva, Inc. received a nasdaq deficiency notice notice regarding audit committee (rules 5605, 5605(a)(2), 5605(c)(4)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: audit committee
  - Rules: 5605, 5605(a)(2), 5605(c)(4)
  source text: August 2, 2023, Innoviva, Inc. (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, due to Dr. Deborah L. Birx’s previously disclosed resignation from the Company’s Board of Directors (the “Board”), the Company is not in compliance with Nasdaq’s audit committee composition requirements, as set forth in Nasdaq Listing Rule 5605, which requires that the Audit Committee of the Board (the “Audit Committee”) be comprised of at least three “independent directors” (as defined in Nasdaq Listing
  evidence_url: https://www.sec.gov/Archives/edgar/data/1080014/000110465923088390/0001104659-23-088390-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.